Plus Therapeutics Appoints Dr. An van Es-Johansson to Board of Directors
02 janv. 2020 16h15 HE
|
Plus Therapeutics, Inc.
AUSTIN, Texas, Jan. 02, 2020 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that Dr. An van Es-Johansson has joined the Company’s Board of Directors to...
Plus Therapeutics Reports Third Quarter 2019 Financial and Business Results
14 nov. 2019 16h05 HE
|
Plus Therapeutics, Inc.
AUSTIN, Texas, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced financial and business results for the third quarter of 2019. Third...
Plus Therapeutics Reports Q2 2019 Financial and Business Results
15 août 2019 19h21 HE
|
Plus Therapeutics, Inc.
AUSTIN, Texas, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced Q2 2019 financial results and provided updates on corporate activities. Q2...